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In the present work the potential of a new-tailored made drug delivery system, obtained by the intercalation of 
the antibiotic metronidazole (MNE) into the K10-montmorillonite clay (MMT) has been evaluated.
7KHLQWHUHVWLQWKLV¿HOGFRPHVIURPWKHFRQVLGHUDWLRQWKDWWKHSKDUPDFRNLQHWLFSUR¿OHRIWKHFRQYHQWLRQDO
tablet metronidazole indicates that the dosage form not only provides minimal amount of metronidazole for 
local action but it also holds unwanted systemic effects. This way, the design of more effective strategies for 
the administration of metronidazole, aiming at minimizing secondary effects, increasing drug bioavailability 
DQGVWDELOLW\RUHYHQH[KLELWLQJKLJKDFFXUDF\LQUHDFKLQJWKHWDUJHWKDVEHFRPHVLJQL¿FDQW
In this perspective a series of MNE/MMT hybrids have been prepared by varying the pH and the amount of 
loaded drug. Complementary kinetic and equilibrium studies have been carried out in order to elucidate the 
adsorption mechanism of the MNE into the MMT and to establish the nature of the interactions involved in 
the hybrid MNE/MMT formation. Moreover, the interactions sites of the clay surface have been proposed on 
WKHEDVHVRIWKH;5'UHVXOWV
The gathered results allowed us to establish that the adsorption process strongly depends on the pH 
conditions and to propose a multistep adsorption mechanism involving the neutral and the cationic form of 
the drug, which interact with different sites of the clay surfaces, i.e. the interlayer region and the faces of the 
lamella.
The drug release kinetics has been then studied under physiological pH mimicking conditions simulating 
WKHRUDOGUXJDGPLQLVWUDWLRQDQGGHOLYHU\7KHLQYHVWLJDWLRQRIWKHUHOHDVHSUR¿OHVDQGWKHFRPSDULVRQZLWK
the commercial formulation of the drug reveal not only that the new-tailor made formulation could be fruitful 
exploited for successfully prolonged the action of drug in the target site but the use of these nanodevices 
reduce both time and costs for the drug delivery.
 
